At a Glance
Dosage
Only in BPC-157
subcutaneous injection
| Level | Dose |
|---|---|
| Threshold | 50 mcg |
| Light | 100–200 mcg |
| Common | 250–500 mcg |
| Strong | 500–750 mcg |
| Heavy | 1000 mcg |
oral
| Level | Dose |
|---|---|
| Threshold | 100 mcg |
| Light | 200–500 mcg |
| Common | 500–1000 mcg |
| Strong | 1000–1500 mcg |
Duration
Only in BPC-157
Only in Oxytocin
Intranasal
Total: 2 hrs – 5 hrsPeak
Offset
Afterglow
Onset15 min – 30 min
Come Up10 min – 20 min
Peak30 min – 1.5 hrs
Effects
Shared Effects1
Unique to BPC-1575
Safety
Interaction: BPC-157 + Oxytocin
No direct interaction data available between these substances. This does not mean the combination is safe.
BPC-157 — Dangerous Interactions
No dangerous interactions recorded.
Oxytocin — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between BPC-157 and Oxytocin?
BPC-157 is classified as a Peptide (Synthetic pentadecapeptide) while Oxytocin is classified as a Neuropeptide (Neuropeptide, Cyclic nonapeptide). They share 1 effects in common, with 5 effects unique to BPC-157 and 6 unique to Oxytocin.
Is it safe to combine BPC-157 and Oxytocin?
There is no direct interaction data available for combining BPC-157 and Oxytocin. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, BPC-157 or Oxytocin?
BPC-157 and Oxytocin are typically administered via different routes, making a direct potency comparison difficult. They belong to different pharmacological profiles and should not be compared by dose alone.